Cite
HARVARD Citation
George, D. et al. (2019). Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration‐resistant prostate cancer. Prostate. 79 (15), pp. 1752-1761. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
George, D. et al. (2019). Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration‐resistant prostate cancer. Prostate. 79 (15), pp. 1752-1761. [Online].